$25MSeries C, 15 October 2025
Complete Phase II trials of OMN6
- Amount
- $25M
- Stage
- Series C
- Announced
- 15 October 2025
- Lead
- Harel Insurance & Finance
- Other investors
- EIC Fund
- Use of funds
- Complete Phase II trials of OMN6
- Checked
- Announced by the company
- Sources
- Omnix Medical raises $25 million Series C to tackle drug-resistant infections - CTech biospace.com
Omnix Medical raises $25 million Series C to tackle drug-resistant infections - CTech CTech